SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2024

Stockholders' Equity Note [Abstract]

Schedule of number of options and exercise price

Grant date	Description	Number of options		Exercise price
March 22, 2022	2012 Plan		50,000		$6.59
May, 2022	2012 Plan		70,000		$6.42-$6.56
December 1, 2022	2022 Plan		50,000		$6.42
January 9, 2023	2022 Plan		50,000		6.31
February 10, 2023	2022 Plan		35,000		6.31
March 29, 2023	2012 Plan		35,000		6.07
May 30, 2023	2022 Plan		30,000		6.45
August 28, 2023	2022 Plan		40,000		8.00
March 6, 2024	2022 Plan to senior executive		175,000		$14.16

Schedule of Stock Options Assumptions

	2024	2023	2022
Expected stock price volatility	49.10%	48% - 54.8%	48.4% - 54.48%
Expected option life (in years)	4.6	4.6	1-5
Risk free interest rate	4.18%	3.71% - 4.54%	0.63% - 4.04%
Dividend yield	0%	0%	0%

Schedule of Stock Option Activity

	Year ended December 31,					Year ended December 31,					Year ended December 31,
	2024					2023					2022
	Number of options			Weighted average exercise price		Number of options			Weighted average exercise price		Number of options			Weighted average exercise price
Outstanding at the beginning of the year		625,000		$	7.31		675,000		$	7.17		720,000		$	6.8
Granted		175,000			14.16		190,000			6.63		170,000			6.56
Forfeited							(196,614	)		6.52		(178,150	)		5.63
Exercised*		(314,375	)		7.85		(43,386	)		5.68		(36,850	)		5.25
Outstanding at the end of the year		485,625			9.43		625,000			7.31		675,000			7.17
Exercisable at the end of the year		171,561			7.05		373,438			7.91		412,813		$	7.54

Schedule of summarizes information concerning outstanding and exercisable awards

awards outstanding				awards exercisable
Exercise price		Number of awards outstanding at the end of the year		Weighted average remaining contractual life (years)		Number of awards exercisable at the end of year		Weighted average remaining contractual life (years)
	5.91	$	18,750		3.24		17,187		3.24
	6.07		35,000		5.24		15,312		5.24
	6.23		35,000		5.11		15,312		5.11
	6.31		28,125		5.02
	6.42		20,000		4.33		12,500		4.33
	6.45		18,750		5.41
	6.59		25,000		4.92
	7.00		100,000		3.66		81,250		3.66
	8.90		10,000		1.17		10,000		1.17
	9.12		20,000		0.36		20,000		0.36
	14.16		175,000		6.18

Schedule of share-based compensation expenses

	Year ended December 31,
	2024		2023		2022
Cost of revenue		144		-		-
Research and development		22		-		-
Sales and marketing		36		-		-
General and administrative		193		190		226
Total stock-based compensation		395		190		226